Articles Tagged With:
-
WHO Convenes Zika Panel: Fate of the Olympics
Relenting to a growing chorus of international concern, the WHO will seek the opinion of a committee of infectious disease experts before it makes a final decision on allowing the Summer Olympics to be held in Rio de Janeiro.
-
Another Brick in the Wall: Colistin-resistant E.coli
The possible emergence of untreatable E. coli — a common cause of urinary tract and other infections in the community — is enough to rudely awake a medical epidemiologist in the middle of the night. It is a sobering development that the CDC has been concerned about for some time.
-
FDA Issues Alert on Devices
The FDA issued a June 1, 2016, alert that some of the Mycobacterium chimaera infections acquired by cardiothoracic patients in the U.S. may be linked to the Stöckert 3T Heater-Cooler System manufactured by the Sorin Group in Germany.
-
New CDC Guidelines to Identify NTM Infections
Hospitals performing surgeries requiring cardiopulmonary bypass should consider taking the following steps to identify patients at risk, the CDC recommends. Patients meeting the following criteria may represent heater-cooler unit-associated infection and may warrant additional investigation.
-
Cardiac Surgery Devices Linked to Fatal Infections
An “insidious” under-the-radar outbreak of waterborne bacteria aerosolized by heater-cooler devices commonly used in cardiothoracic surgery is emerging as a clear and present danger to patient safety, a veteran epidemiologist recently warned at a meeting of infectious disease physicians in Atlanta.
-
Acetazolamide in Mechanically Ventilated Patients with COPD: Is There a Benefit?
Compared to placebo, the use of acetazolamide in mechanically ventilated patients with COPD does not significantly reduce the duration of mechanical ventilation. -
New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit with Low and High Aspirin Doses
A dedicated analysis of the COGENT trial involving coronary artery disease patients on dual antiplatelet therapy shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin, and similar benefits of prophylactic proton pump inhibitor therapy. -
Communication Facilitators Potentially Can Improve Care for the Sickest ICU Patients
Highly trained communication facilitators who counseled families and met with physicians and nurses were shown to decrease symptoms of depression in family members at six months and decreased ICU length of stay without affecting mortality. -
Rivaroxaban in the Real World
A large Phase IV registry study shows that rivaroxaban is associated with a very low incidence of major bleeding, death, or stroke. Also, adherence to therapy was much higher than observed in other studies with vitamin K antagonists. -
Delaying Intubation in Severe Alcohol Withdrawal
Delaying intubation until aspiration or cardiopulmonary decompensation did not affect mortality but increased the incidence of pneumonia and length of stay.